Novomix 30 is a pre-mixed insulin medication designed for the treatment of diabetes mellitus in adults, adolescents, and children aged 10 years and above. It is a biphasic insulin analog that contains a mixture of 30% soluble insulin aspart and 70% insulin aspart protamine, which provides both rapid-acting and intermediate-acting insulin effects. This combination allows for better control of blood glucose levels by offering a quick onset to manage post-meal glucose spikes, as well as sustained action to maintain glucose levels more evenly throughout the day. Novomix 30 is typically administered via injection and is used in accordance with a treatment plan that may include diet, exercise, and regular blood sugar monitoring. It is essential for users to follow their healthcare provider's instructions closely when using Novomix 30 to ensure optimal diabetes management and to minimize potential side effects.